Across TCGA pan-cancer cohorts, MIR517A RNA is linked to patient survival in 3 of 34 cancer types, making it the most broadly survival-associated MIR517A data layer compared with 2 for mutation status.

The strongest signal is observed in brain lower grade glioma (LGG), where higher MIR517A RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR517A expression acts as an unfavorable survival marker.

LGG, PCPG, and STAD are the cancer types where MIR517A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Tertile	All	0.295	0.811	.005	18	view →
PCPG	DFS	Tertile	All	0.086	0.846	.001	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: MIR517A tumor-vs-normal RNA expression · all MIR517A data types